Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Genetic
Study Type: Observational
SUMMARY

Studying genetic predisposition in autoimmune neurological diseases could help improve diagnostic accuracy and offer new treatment possibilities

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

⁃ For the first cohort, the inclusion criteria were:

• Patients diagnosed with NMOSD associated with AQP4 autoantibodies who meet the 2015 diagnostic criteria and have at least one of the listed autoimmune comorbidities.

• Patients diagnosed with myasthenia gravis associated with AChR autoantibodies who also have another autoimmune comorbidity from the list.

• Patients diagnosed with autoimmune encephalitis who are positive for LGI1 and CASPR2 autoantibodies and have at least one additional autoimmune comorbidity.

⁃ The second cohort included adults with dominant pathogenic AIRE mutations or homozygous AIRE mutations.

Locations
Other Locations
Italy
Fondazione Policlinico Universitario Agostino Gemelli, IRCSS Roma
RECRUITING
Roma
Contact Information
Primary
Raffaele Iorio, MD
raffaele.iorio@policlinicogemelli.it
3347185128
Backup
Martina Marini, MD
martinamarini95@gmail.com
3928425936
Time Frame
Start Date: 2024-11-06
Estimated Completion Date: 2027-01-06
Participants
Target number of participants: 40
Treatments
First cohort - Patients with diagnosis of a neurological autoimmune disease
For the first cohort, the inclusion criteria were:~* Patients diagnosed with NMOSD associated with AQP4 autoantibodies who meet the 2015 diagnostic criteria and have at least one of the listed autoimmune comorbidities.~* Patients diagnosed with myasthenia gravis associated with AChR autoantibodies who also have another autoimmune comorbidity from the list.~* Patients diagnosed with autoimmune encephalitis who are positive for LGI1 and CASPR2 autoantibodies and have at least one additional autoimmune comorbidity.~The only exclusion criterion was the presence of untreated thymoma or a history of thymoma.
Second cohort - Patients with AIRE mutations
The second cohort included adults with dominant pathogenic AIRE mutations or homozygous AIRE mutations.
Sponsors
Collaborators: University of Bergen
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.